Netherlands Healthcare (Pharma and Medical Devices) Market Analysis, Regulatory, Reimbursement and Competitive Landscape

Netherlands Healthcare (Pharma and Medical Devices) Market Analysis, Regulatory, Reimbursement and Competitive Landscape

Summary

GlobalData, the industry analysis specialist, has released its latest report: “CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - The Netherlands”. The report is an essential source of information on analysis of the healthcare, regulatory and reimbursement landscape in the Netherlands. It identifies the key trends in the country’s healthcare market and provides insights into its demographic, regulatory and reimbursement landscape, and healthcare infrastructure. Most importantly, the report provides valuable insights into the trends and segmentation of its pharmaceutical and medical device markets. It uses data and information sourced from proprietary databases, secondary research, and in-house analysis by GlobalData’s team of industry experts.

The Netherlands is an emerging, advanced healthcare market with universal access to healthcare facilities and insurance. In 2022, the Dutch government invested $325 million in preclinical cancer treatment development, to promote the expansion of the Dutch National Growth Fund in order to provide biotechnology with specific capabilities that will speed up the development of oncology prospects. The Dutch pharmaceutical market, in terms of US dollars, was worth $5.0 billion in 2015, which increased at a Compound Annual Growth Rate (CAGR) of 2.7% to $5.7 billion in 2020. The market value is expected to increase and is forecast to reach $6.8 billion by 2027. The pharmaceutical market in terms of Euros (€) was worth €4.5 billion in 2015, which increased at a CAGR of 2.2% to €5.0 billion in 2020. The market is expected to increase and is forecast to reach €5.8 billion in 2027. In 2016, the Netherlands’ medical devices market was worth $3.3 billion, which increased at a CAGR of 3.9% to $4.0 billion in 2021. The development of wearable technologies, such as smart fabrics with embedded sensors, glasses that display 3D organ images, tracker-equipped rings, bracelets, applications, and breathing devices, increased the medical device market in 2020. In 2021, the Netherlands developed a Personal Health Train platform that provides access to health data for researchers and innovators in the field of healthcare. It allows for limited data access while following privacy laws to promote patient participation.

Scope

The report provides information on the healthcare, regulatory, and reimbursement landscape in the Netherlands, and includes -

• An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers.
• Profiles and SWOT analyses of the major players in the pharmaceutical market: Sanofi, Pfizer, Novartis, GSK, and Pharming.
• Profiles and SWOT analyses of the major players in the medical device market: Fresenius, Abbott, Siemens Healthineers, GE Healthcare, and Qiagen.
• An insightful review of the COVID-19 epidemiology, COVID-19 impact and developments in the healthcare market, HealthTech landscape, reimbursement, and regulatory landscape, with analysis covering details of the country’s healthcare reimbursement process, regulatory agencies, and the approval processes for new drugs and medical devices.
• Detailed analysis of the country’s healthcare policy highlights, demographics, healthcare infrastructure, and healthcare expenditure.
• An overview of the opportunities for and challenges to growth in the Netherlands healthcare market.

Reasons to Buy

This report will enhance your decision-making capability by allowing you to -

• Develop business strategies by understanding the trends shaping and driving the Netherlands healthcare market
• Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments and companies likely to impact the Netherlands healthcare market in the future
• Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing competitors’ performance
• Organize your sales and marketing efforts by identifying the market categories and segments that present the most opportunities for consolidation, investment and strategic partnership